Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Pathog ; 6(4): e1000839, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20419122

ABSTRACT

The stable infection of host macrophages by Mycobacterium tuberculosis (Mtb) involves, and depends on, the attenuation of the diverse microbicidal responses mounted by the host cell. This is primarily achieved through targeted perturbations of the host cellular signaling machinery. Therefore, in view of the dependency of the pathogen on host molecules for its intracellular survival, we wanted to test whether targeting such factors could provide an alternate route for the therapeutic management of tuberculosis. To first identify components of the host signaling machinery that regulate intracellular survival of Mtb, we performed an siRNA screen against all known kinases and phosphatases in murine macrophages infected with the virulent strain, H37Rv. Several validated targets could be identified by this method where silencing led either to a significant decrease, or enhancement in the intracellular mycobacterial load. To further resolve the functional relevance of these targets, we also screened against these identified targets in cells infected with different strains of multiple drug-resistant mycobacteria which differed in terms of their intracellular growth properties. The results obtained subsequently allowed us to filter the core set of host regulatory molecules that functioned independently of the phenotypic variations exhibited by the pathogen. Then, using a combination of both in vitro and in vivo experimentation, we could demonstrate that at least some of these host factors provide attractive targets for anti-TB drug development. These results provide a "proof-of-concept" demonstration that targeting host factors subverted by intracellular Mtb provides an attractive and feasible strategy for the development of anti-tuberculosis drugs. Importantly, our findings also emphasize the advantage of such an approach by establishing its equal applicability to infections with Mtb strains exhibiting a range of phenotypic diversifications, including multiple drug-resistance. Thus the host factors identified here may potentially be exploited for the development of anti-tuberculosis drugs.


Subject(s)
Host-Parasite Interactions/genetics , Macrophages/parasitology , Mycobacterium tuberculosis/genetics , RNA, Small Interfering/genetics , Tuberculosis/genetics , Animals , Antitubercular Agents/pharmacology , Female , Gene Expression , Gene Expression Profiling , Gene Expression Regulation, Bacterial , Mice , Mice, Inbred BALB C , Microscopy, Confocal , Oligonucleotide Array Sequence Analysis
2.
Cell ; 140(5): 731-43, 2010 Mar 05.
Article in English | MEDLINE | ID: mdl-20211141

ABSTRACT

We performed a genome-wide siRNA screen to identify host factors that regulated pathogen load in human macrophages infected with a virulent strain of Mycobacterium tuberculosis. Iterative rounds of confirmation, followed by validation, identified 275 such molecules that were all found to functionally associate with each other through a dense network of interactions. This network then yielded to a molecular description of the host cell functional modules that were both engaged and perturbed by the pathogen. Importantly, a subscreen against a panel of field isolates revealed that the molecular composition of the host interface varied with both genotype and the phenotypic properties of the pathogen. An analysis of these differences, however, permitted identification of those host factors that were invariantly involved, regardless of the diversification in adaptive mechanisms employed by the pathogen. Interestingly, these factors were found to predominantly function through the regulation of autophagy.


Subject(s)
Genome-Wide Association Study , Host-Pathogen Interactions , Macrophages/microbiology , Mycobacterium tuberculosis/physiology , Genome, Human , Genomic Library , Humans , Microbial Viability , Mycobacterium tuberculosis/immunology , RNA, Small Interfering/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...